author_facet Justilien, Verline
Fields, Alan P.
Justilien, Verline
Fields, Alan P.
author Justilien, Verline
Fields, Alan P.
spellingShingle Justilien, Verline
Fields, Alan P.
Current Protocols in Pharmacology
Utility and Applications of Orthotopic Models of Human Non‐Small Cell Lung Cancer (NSCLC) for the Evaluation of Novel and Emerging Cancer Therapeutics
Pharmacology
author_sort justilien, verline
spelling Justilien, Verline Fields, Alan P. 1934-8282 1934-8290 Wiley Pharmacology http://dx.doi.org/10.1002/0471141755.ph1427s62 <jats:title>Abstract</jats:title><jats:p>Lung cancer is a leading cause of cancer deaths worldwide. Despite advances in chemotherapy, radiation therapy, and surgery, lung cancer continues to have a low 5‐year survival rate, highlighting a dire need for more effective means of prevention, diagnosis, prognosis, and treatment. Mouse models that recapitulate the clinical features of advanced human lung cancer are critical for testing novel therapeutic approaches. This unit describes a highly reproducible, easy‐to‐establish orthotopic murine model of lung cancer, provides methods for in vivo imaging and monitoring of tumor growth, and discusses the usefulness of this model for translational lung cancer research and the development of therapeutic strategies. <jats:italic>Curr. Protoc. Pharmacol</jats:italic>. 62:14.27.1‐14.27.17. © 2013 by John Wiley &amp; Sons, Inc.</jats:p> Utility and Applications of Orthotopic Models of Human Non‐Small Cell Lung Cancer (NSCLC) for the Evaluation of Novel and Emerging Cancer Therapeutics Current Protocols in Pharmacology
doi_str_mv 10.1002/0471141755.ph1427s62
facet_avail Online
finc_class_facet Chemie und Pharmazie
format ElectronicArticle
fullrecord blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTAwMi8wNDcxMTQxNzU1LnBoMTQyN3M2Mg
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTAwMi8wNDcxMTQxNzU1LnBoMTQyN3M2Mg
institution DE-D275
DE-Bn3
DE-Brt1
DE-D161
DE-Gla1
DE-Zi4
DE-15
DE-Pl11
DE-Rs1
DE-105
DE-14
DE-Ch1
DE-L229
imprint Wiley, 2013
imprint_str_mv Wiley, 2013
issn 1934-8282
1934-8290
issn_str_mv 1934-8282
1934-8290
language English
mega_collection Wiley (CrossRef)
match_str justilien2013utilityandapplicationsoforthotopicmodelsofhumannonsmallcelllungcancernsclcfortheevaluationofnovelandemergingcancertherapeutics
publishDateSort 2013
publisher Wiley
recordtype ai
record_format ai
series Current Protocols in Pharmacology
source_id 49
title Utility and Applications of Orthotopic Models of Human Non‐Small Cell Lung Cancer (NSCLC) for the Evaluation of Novel and Emerging Cancer Therapeutics
title_unstemmed Utility and Applications of Orthotopic Models of Human Non‐Small Cell Lung Cancer (NSCLC) for the Evaluation of Novel and Emerging Cancer Therapeutics
title_full Utility and Applications of Orthotopic Models of Human Non‐Small Cell Lung Cancer (NSCLC) for the Evaluation of Novel and Emerging Cancer Therapeutics
title_fullStr Utility and Applications of Orthotopic Models of Human Non‐Small Cell Lung Cancer (NSCLC) for the Evaluation of Novel and Emerging Cancer Therapeutics
title_full_unstemmed Utility and Applications of Orthotopic Models of Human Non‐Small Cell Lung Cancer (NSCLC) for the Evaluation of Novel and Emerging Cancer Therapeutics
title_short Utility and Applications of Orthotopic Models of Human Non‐Small Cell Lung Cancer (NSCLC) for the Evaluation of Novel and Emerging Cancer Therapeutics
title_sort utility and applications of orthotopic models of human non‐small cell lung cancer (nsclc) for the evaluation of novel and emerging cancer therapeutics
topic Pharmacology
url http://dx.doi.org/10.1002/0471141755.ph1427s62
publishDate 2013
physical
description <jats:title>Abstract</jats:title><jats:p>Lung cancer is a leading cause of cancer deaths worldwide. Despite advances in chemotherapy, radiation therapy, and surgery, lung cancer continues to have a low 5‐year survival rate, highlighting a dire need for more effective means of prevention, diagnosis, prognosis, and treatment. Mouse models that recapitulate the clinical features of advanced human lung cancer are critical for testing novel therapeutic approaches. This unit describes a highly reproducible, easy‐to‐establish orthotopic murine model of lung cancer, provides methods for in vivo imaging and monitoring of tumor growth, and discusses the usefulness of this model for translational lung cancer research and the development of therapeutic strategies. <jats:italic>Curr. Protoc. Pharmacol</jats:italic>. 62:14.27.1‐14.27.17. © 2013 by John Wiley &amp; Sons, Inc.</jats:p>
container_issue 1
container_start_page 0
container_title Current Protocols in Pharmacology
container_volume 62
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
_version_ 1792343419350155264
geogr_code not assigned
last_indexed 2024-03-01T16:51:25.199Z
geogr_code_person not assigned
openURL url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=Utility+and+Applications+of+Orthotopic+Models+of+Human+Non%E2%80%90Small+Cell+Lung+Cancer+%28NSCLC%29+for+the+Evaluation+of+Novel+and+Emerging+Cancer+Therapeutics&rft.date=2013-10-01&genre=article&issn=1934-8290&volume=62&issue=1&jtitle=Current+Protocols+in+Pharmacology&atitle=Utility+and+Applications+of+Orthotopic+Models+of+Human+Non%E2%80%90Small+Cell+Lung+Cancer+%28NSCLC%29+for+the+Evaluation+of+Novel+and+Emerging+Cancer+Therapeutics&aulast=Fields&aufirst=Alan+P.&rft_id=info%3Adoi%2F10.1002%2F0471141755.ph1427s62&rft.language%5B0%5D=eng
SOLR
_version_ 1792343419350155264
author Justilien, Verline, Fields, Alan P.
author_facet Justilien, Verline, Fields, Alan P., Justilien, Verline, Fields, Alan P.
author_sort justilien, verline
container_issue 1
container_start_page 0
container_title Current Protocols in Pharmacology
container_volume 62
description <jats:title>Abstract</jats:title><jats:p>Lung cancer is a leading cause of cancer deaths worldwide. Despite advances in chemotherapy, radiation therapy, and surgery, lung cancer continues to have a low 5‐year survival rate, highlighting a dire need for more effective means of prevention, diagnosis, prognosis, and treatment. Mouse models that recapitulate the clinical features of advanced human lung cancer are critical for testing novel therapeutic approaches. This unit describes a highly reproducible, easy‐to‐establish orthotopic murine model of lung cancer, provides methods for in vivo imaging and monitoring of tumor growth, and discusses the usefulness of this model for translational lung cancer research and the development of therapeutic strategies. <jats:italic>Curr. Protoc. Pharmacol</jats:italic>. 62:14.27.1‐14.27.17. © 2013 by John Wiley &amp; Sons, Inc.</jats:p>
doi_str_mv 10.1002/0471141755.ph1427s62
facet_avail Online
finc_class_facet Chemie und Pharmazie
format ElectronicArticle
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
geogr_code not assigned
geogr_code_person not assigned
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTAwMi8wNDcxMTQxNzU1LnBoMTQyN3M2Mg
imprint Wiley, 2013
imprint_str_mv Wiley, 2013
institution DE-D275, DE-Bn3, DE-Brt1, DE-D161, DE-Gla1, DE-Zi4, DE-15, DE-Pl11, DE-Rs1, DE-105, DE-14, DE-Ch1, DE-L229
issn 1934-8282, 1934-8290
issn_str_mv 1934-8282, 1934-8290
language English
last_indexed 2024-03-01T16:51:25.199Z
match_str justilien2013utilityandapplicationsoforthotopicmodelsofhumannonsmallcelllungcancernsclcfortheevaluationofnovelandemergingcancertherapeutics
mega_collection Wiley (CrossRef)
physical
publishDate 2013
publishDateSort 2013
publisher Wiley
record_format ai
recordtype ai
series Current Protocols in Pharmacology
source_id 49
spelling Justilien, Verline Fields, Alan P. 1934-8282 1934-8290 Wiley Pharmacology http://dx.doi.org/10.1002/0471141755.ph1427s62 <jats:title>Abstract</jats:title><jats:p>Lung cancer is a leading cause of cancer deaths worldwide. Despite advances in chemotherapy, radiation therapy, and surgery, lung cancer continues to have a low 5‐year survival rate, highlighting a dire need for more effective means of prevention, diagnosis, prognosis, and treatment. Mouse models that recapitulate the clinical features of advanced human lung cancer are critical for testing novel therapeutic approaches. This unit describes a highly reproducible, easy‐to‐establish orthotopic murine model of lung cancer, provides methods for in vivo imaging and monitoring of tumor growth, and discusses the usefulness of this model for translational lung cancer research and the development of therapeutic strategies. <jats:italic>Curr. Protoc. Pharmacol</jats:italic>. 62:14.27.1‐14.27.17. © 2013 by John Wiley &amp; Sons, Inc.</jats:p> Utility and Applications of Orthotopic Models of Human Non‐Small Cell Lung Cancer (NSCLC) for the Evaluation of Novel and Emerging Cancer Therapeutics Current Protocols in Pharmacology
spellingShingle Justilien, Verline, Fields, Alan P., Current Protocols in Pharmacology, Utility and Applications of Orthotopic Models of Human Non‐Small Cell Lung Cancer (NSCLC) for the Evaluation of Novel and Emerging Cancer Therapeutics, Pharmacology
title Utility and Applications of Orthotopic Models of Human Non‐Small Cell Lung Cancer (NSCLC) for the Evaluation of Novel and Emerging Cancer Therapeutics
title_full Utility and Applications of Orthotopic Models of Human Non‐Small Cell Lung Cancer (NSCLC) for the Evaluation of Novel and Emerging Cancer Therapeutics
title_fullStr Utility and Applications of Orthotopic Models of Human Non‐Small Cell Lung Cancer (NSCLC) for the Evaluation of Novel and Emerging Cancer Therapeutics
title_full_unstemmed Utility and Applications of Orthotopic Models of Human Non‐Small Cell Lung Cancer (NSCLC) for the Evaluation of Novel and Emerging Cancer Therapeutics
title_short Utility and Applications of Orthotopic Models of Human Non‐Small Cell Lung Cancer (NSCLC) for the Evaluation of Novel and Emerging Cancer Therapeutics
title_sort utility and applications of orthotopic models of human non‐small cell lung cancer (nsclc) for the evaluation of novel and emerging cancer therapeutics
title_unstemmed Utility and Applications of Orthotopic Models of Human Non‐Small Cell Lung Cancer (NSCLC) for the Evaluation of Novel and Emerging Cancer Therapeutics
topic Pharmacology
url http://dx.doi.org/10.1002/0471141755.ph1427s62